Health Canada
- Status: approved
🇨🇦 Phase C: Torasemide in Canada
Phase C: Torasemide (Phase C: Torasemide) regulatory status in Canada.
Marketing authorisation
Phase C: Torasemide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Phase C: Torasemide approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Phase C: Torasemide in Canada?
National Institute of Cardiology, Warsaw, Poland is the originator. The local marketing authorisation holder may differ — check the official source linked above.